BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32017817)

  • 1. Evaluation of the effectiveness of rehabilitation of people diagnosed with schizophrenia using clinical tools, psychological tests, QEEG, and the brain-derived neurotrophic factor (BDNF).
    Markiewcz RA; Markiewicz-Gospodarek A; Kozioł M; Szulecka B; Olajossy M; Plech T
    Psychiatr Pol; 2019 Dec; 53(6):1275-1292. PubMed ID: 32017817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Clinical, Cognitive, and Psychosocial Dysfunctions in Patients with Schizophrenia: A Neurofeedback Randomized Control Trial.
    Markiewicz R; Markiewicz-Gospodarek A; Dobrowolska B; Łoza B
    Neural Plast; 2021; 2021():4488664. PubMed ID: 34434228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and Social Rehabilitation in Schizophrenia-From Neurophysiology to Neuromodulation. Pilot Study.
    Markiewicz R; Dobrowolska B
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32517043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Beppu H; Tominaga H
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforcement of Self-Regulated Brain Activity in Schizophrenia Patients Undergoing Rehabilitation.
    Markiewicz R; Dobrowolska B
    Biomed Res Int; 2021; 2021():8030485. PubMed ID: 33855083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
    Chiou YJ; Huang TL
    World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can brain-derived neurotrophic factor (BDNF) be an indicator of effective rehabilitation interventions in schizophrenia?
    Markiewicz R; Kozioł M; Olajossy M; Masiak J
    Psychiatr Pol; 2018 Oct; 52(5):819-834. PubMed ID: 30584816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture.
    Sun ZL; Liu J; Guo W; Jiang T; Ma C; Li WB; Tang YL; Ling SH
    Psychiatry Res; 2016 Oct; 244():370-5. PubMed ID: 27525826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
    Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
    Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.
    Yang F; Wang K; Du X; Deng H; Wu HE; Yin G; Ning Y; Huang X; Teixeira AL; de Quevedo J; Soares JC; Li X; Lang X; Zhang XY
    Psychopharmacology (Berl); 2019 Feb; 236(2):753-762. PubMed ID: 30456540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
    Bora E
    Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor and matrix metalloproteinase-9 activity during rehabilitation therapy of schizophrenic patients - environmental pilot study.
    Markiewicz R; Markiewicz-Gospodarek AA; Dobrowolska B; Bojar I; Łoza B
    Ann Agric Environ Med; 2023 Jun; 30(2):315-321. PubMed ID: 37387382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of BDNF with cytokines in chronic schizophrenia.
    Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
    Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.